| Attributes |
|
is tumor
|
Yes
|
|
gap_consent_short_name
|
GRU
|
|
sex
|
male
|
|
subject is affected
|
Yes
|
|
gap_sample_id
|
5064296
|
|
submitted sample id
|
09266_009_8_T_000018C41L
|
|
study name
|
A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
|
|
study disease
|
Squamous Cell Carcinoma of Head and Neck
|
|
study design
|
Case Set
|
|
submitter handle
|
NCI_LA_HNSCC_Everolimus
|
|
submitted subject id
|
009
|
|
biospecimen repository
|
NCI_LA_HNSCC_Everolimus
|
|
gap_subject_id
|
4298125
|
|
body site
|
OROPHARYNX
|
|
analyte type
|
DNA
|
|
biospecimen repository sample id
|
09266_009_8_T_000018C41L
|
|
gap_consent_code
|
1
|
|
gap_accession
|
phs002986
|
|
